Solithromycin Pharmacokinetics in Plasma and Dried Blood Spots and Safety in Adolescents
Daniel González(University of North Carolina at Chapel Hill), Michael Cohen‐Wolkowiez(Duke University), Natalie Neu(Columbia University Irving Medical Center), Kara Keedy(Cempra Pharmaceuticals (United States)), Leena Bhattacharya-Mithal(Lurie Children's Hospital), Amira Al‐Uzri(Oregon Health & Science University), Prabhavathi Fernandes(Global Antibiotic Research & Development Partnership), Daniel K. Benjamin(Duke University), Laura P. James(University of Arkansas for Medical Sciences), Christoph P. Hornik(Duke University), Debra L. Palazzi(Baylor College of Medicine), John S. Bradley(Rady Children's Hospital-San Diego), P. Brian Smith(Duke University), Theresa Jasion(Duke University)
Cited by 15
Related Papers
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.2k
Significance of Protein Binding in Pharmacokinetics and Pharmacodynamics
|Journal of Pharmaceutical Sciences|2009|337
A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study)
|Clinical Infectious Diseases|2020|232
Analysis of the clinical pipeline of treatments for drug resistant bacterial infections: despite progress, more action is needed
|Archive ouverte UNIGE (University of Geneva)|2022|221